Security key
705015105
- Security type / class
- Equity / SPONSORED ADR
- Total 13F shares
- 26,761
- Total 13F value
- $425,233
- Share change
- +9,275
- SEC-reported price per share
- $15.89
- Number of holders
- 2
- Value change
- +$147,380
- Number of buys
- 1
Report period
Q2 2026
Institutions
2
Top holders
2
PSO full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
PEARSON PLC SEC filings
PEARSON PLC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 705015105
Recent filing periods:
Ownership snapshot
Top reported holders of PSO - PEARSON PLC - SPONSORED ADR (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cevian Capital II GP LTD
Disclosed value leader
Exor N.V.
Comparable rows
4/15
Latest evidence
16 Apr 2026
13D/G
13F
Lead comparable stake: 19%
11 rows are not safely comparable across share classes.
13D/G row: Cevian Capital II GP LTD
Showing 1-6 of 15 holder rows.
Quick read
Cevian Capital II GP LTD leads the comparable SEC ownership view at 19%.
4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cevian Capital II GP LTD's linked filing trail.
Comparable ownership
Top 4
Cevian Capital II GP LTD
19%
BlackRock, Inc.
8.2%
Exor N.V.
617%
ORBIMED ADVISORS LLC
21%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cevian Capital II GP LTD |
13D/G
|
19%
|
—
116,765,346 shares
|
$0 | 16 Apr 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
8.2%
from 13D/G
|
$35,230,879
2,683,235 shares
|
— | 31 Mar 2026 |
| Exor N.V. |
13F
Company
|
617%
|
$5,001,704,778
182,543,970 shares
|
— | 31 Mar 2026 |
| ORBIMED ADVISORS LLC |
13F
Company
|
21%
|
$22,079,801
6,210,899 shares
|
— | 31 Mar 2026 |
| MORGAN STANLEY |
13F
Company
|
—
class O/S missing
|
$52,504,417
3,998,813 shares
|
— | 31 Mar 2026 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
class O/S missing
|
$31,671,491
2,412,147 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
26,761
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
199
Q2 2026 holders
2
Holder diff
-197
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend